Skip to main content

Lauren Tengler

Head of Investor Relations

Boston Scientific Corp (BSX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Boston Scientific Corp publishes a filing, an earnings call transcript or a press release.

Get BSX alerts

About Lauren Tengler

Lauren Tengler is recorded as Head of Investor Relations at Boston Scientific Corp (BSX). Lauren Tengler has spoken on 11 earnings calls and 1 other investor event across 1 company, most recently for Boston Scientific Corp on October 28, 2026. Boston Scientific Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Boston Scientific Corp includes Michael Mahoney (CEO), Jonathan Monson (CFO), Joe Fitzgerald (COO) and 7 others.

Lauren Tengler on recent calls

“With me today are Mike Mahoney, Chairman and Chief Executive Officer, and John Monson, Executive Vice President and Chief Financial Officer. During the Q&A session, Mike and John will be joined by Joe Fitzgerald, Executive Vice President and Group President, Cardiology, and our Chief Medical Officer, Dr. Ken Stein.”
Head of Investor Relations, Boston Scientific Conference Call Discussing Third Quarter Financial Results ·
“With me on today's call are Mike Mahoney, Chairman and Chief Executive Officer, and John Monson, Executive Vice President and Chief Financial Officer. During the Q&A session, Mike and John will be joined by our Chief Medical Officer, Dr. Ken Stein.”
Head of Investor Relations, Boston Scientific Corp Q2 FY2026 Earnings Call ·
“With me today are Mike Mahoney, Chairman and Chief Executive Officer, John Monson, Executive Vice President and Chief Financial Officer. During the Q&A session, Mike and John will be joined by our Chief Medical Officer, Dr. Ken Stein.”
Head of Investor Relations, Boston Scientific Corp Q1 FY2026 Earnings Call ·
“With me to discuss our Champion AF and HyPytho trials are Dr. Ken Stein, our Chief Medical Officer, Dr. Michael Jaff, Chief Medical Officer, Vascular Therapies, and Dr. Brad Sutton, Chief Medical Officer, AF Solutions.”
Head of Investor Relations, Boston Scientific Investor Event at the 75th Annual Scientific Session of the American College of Cardiology ·
“With me today are Mike Mahoney, Chairman and Chief Executive Officer, and John Monson, Executive Vice President and Chief Financial Officer. During the Q&A session, Mike and John will be joined by our Chief Medical Officer, Dr. Ken Stein.”
Head of Investor Relations, Boston Scientific Corp Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Boston Scientific Corp

Recent activity